Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

NCT01656252 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Study stopped per Novartis request due to futility from another study.

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Phase I- Cytarabine & Eltrombopag
DRUG: Phase II- Sequence A
DRUG: Phase II- Sequence B

Sponsor

PrECOG, LLC.

Collaborators

[object Object]
[object Object]